These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31101121)

  • 1. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
    Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
    Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative use of CRISPR and RNAi to modulate integrin α3β1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic α3β1 functions are independent of global regulation of the transcriptome.
    Kenney J; Ndoye A; Lamar JM; DiPersio CM
    PLoS One; 2021; 16(7):e0254714. PubMed ID: 34270616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
    Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
    Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
    Nie J; Dang S; Zhu R; Lu T; Zhang W
    Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.
    Zhou B; Gibson-Corley KN; Herndon ME; Sun Y; Gustafson-Wagner E; Teoh-Fitzgerald M; Domann FE; Henry MD; Stipp CS
    Mol Cancer Res; 2014 Jan; 12(1):143-154. PubMed ID: 24002891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells.
    Mitchell K; Svenson KB; Longmate WM; Gkirtzimanaki K; Sadej R; Wang X; Zhao J; Eliopoulos AG; Berditchevski F; Dipersio CM
    Cancer Res; 2010 Aug; 70(15):6359-67. PubMed ID: 20631072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
    Yang Y; Leonard M; Zhang Y; Zhao D; Mahmoud C; Khan S; Wang J; Lower EE; Zhang X
    Cancer Res; 2018 Jan; 78(2):422-435. PubMed ID: 29187405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
    Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
    Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness.
    Hamyeh M; Bernex F; Larive RM; Naldi A; Urbach S; Simony-Lafontaine J; Puech C; Bakhache W; Solassol J; Coopman PJ; Hendriks WJAJ; Freiss G
    Theranostics; 2020; 10(3):1016-1032. PubMed ID: 31938048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
    Negro G; Aschenbrenner B; Brezar SK; Cemazar M; Coer A; Gasljevic G; Savic D; Sorokin M; Buzdin A; Callari M; Kvitsaridze I; Jewett A; Vasileva-Slaveva M; Ganswindt U; Skvortsova I; Skvortsov S
    Radiol Oncol; 2020 Feb; 54(1):103-118. PubMed ID: 32061169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells.
    Schmucker H; Blanding WM; Mook JM; Wade JF; Park JP; Kwist K; Shah H; Booth BW
    Cell Oncol (Dordr); 2018 Apr; 41(2):159-168. PubMed ID: 29181633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer.
    Aggarwal A; Al-Rohil RN; Batra A; Feustel PJ; Jones DM; DiPersio CM
    BMC Cancer; 2014 Jun; 14():459. PubMed ID: 24950714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis.
    Cagnet S; Faraldo MM; Kreft M; Sonnenberg A; Raymond K; Glukhova MA
    Oncogene; 2014 Aug; 33(34):4286-95. PubMed ID: 24077284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.
    Gallagher EJ; Zelenko Z; Neel BA; Antoniou IM; Rajan L; Kase N; LeRoith D
    Oncogene; 2017 Nov; 36(46):6462-6471. PubMed ID: 28759039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.
    Seachrist DD; Sizemore ST; Johnson E; Abdul-Karim FW; Weber Bonk KL; Keri RA
    Breast Cancer Res; 2017 Jun; 19(1):66. PubMed ID: 28583174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
    Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.